Teacher Retirement System Of Texas Lowered Biogen (BIIB) Position By $3.08 Million; Gen Probe (GPRO) Sentiment Is 0.6

June 19, 2017 - By Ellis Scott

GoPro, Inc. produces cameras and mountable and wearable accessories. The company has market cap of $1.07 billion. The Company’s product offerings include HERO5, which is a line of cloud-connected cameras featuring image stabilization, telemetry, cloud connectivity and voice control; GoPro Plus, which is a cloud storage solution that enables subscribers to access, edit and share content; Quik, which is a mobile editing application that creates edits on a smartphone; Capture, which is a mobile application that allows users to preview and play back shots, control their GoPro cameras and share content on the fly using their smartphones; Karma, which is its compact and foldable drone and versatile stabilization solution that includes the Karma controller, and camera stabilizer, and it all fits in a custom backpack, and Karma Grip, which is a handheld, body-mountable camera stabilizer. It currently has negative earnings.

Teacher Retirement System Of Texas decreased Biogen Inc (BIIB) stake by 4.78% reported in 2016Q4 SEC filing. Teacher Retirement System Of Texas sold 10,890 shares as Biogen Inc (BIIB)’s stock declined 13.45%. The Teacher Retirement System Of Texas holds 216,962 shares with $61.53M value, down from 227,852 last quarter. Biogen Inc now has $54.20B valuation. The stock rose 2.82% or $7.1 reaching $258.84. About 237,439 shares traded. Biogen Inc (NASDAQ:BIIB) has risen 4.94% since June 19, 2016 and is uptrending. It has underperformed by 11.76% the S&P500.

Analysts await GoPro Inc (NASDAQ:GPRO) to report earnings on July, 26. They expect $-0.35 earnings per share, up 45.31% or $0.29 from last year’s $-0.64 per share. After $-0.53 actual earnings per share reported by GoPro Inc for the previous quarter, Wall Street now forecasts -33.96% EPS growth.

Ratings analysis reveals 33% of GoPro’s analysts are positive. Out of 6 Wall Street analysts rating GoPro, 2 give it “Buy”, 3 “Sell” rating, while 1 recommend “Hold”. The lowest target is $6.0 while the high is $19.0. The stock’s average target of $12.13 is 57.53% above today’s ($7.7) share price. GPRO was included in 6 notes of analysts from September 16, 2016. The company was downgraded on Wednesday, November 9 by Dougherty & Company. The stock of GoPro Inc (NASDAQ:GPRO) has “Outperform” rating given on Tuesday, September 20 by Wedbush. The firm has “Underperform” rating given on Friday, February 3 by Robert W. Baird. The stock of GoPro Inc (NASDAQ:GPRO) has “Mkt Perform” rating given on Wednesday, November 9 by Raymond James. As per Friday, January 6, the company rating was downgraded by Longbow. The company was initiated on Friday, September 16 by Bank of America.

Sageview Capital Lp holds 29.25% of its portfolio in GoPro Inc for 999,417 shares. Weatherbie Capital Llc owns 733,776 shares or 0.8% of their US portfolio. Moreover, Btg Pactual Global Asset Management Ltd has 0.34% invested in the company for 42,672 shares. The Pennsylvania-based Hamilton Lane Advisors Llc has invested 0.28% in the stock. Pinnacle Associates Ltd, a New York-based fund reported 1.39 million shares.

About 544,615 shares traded. GoPro Inc (GPRO) has declined 3.73% since June 19, 2016 and is downtrending. It has underperformed by 20.43% the S&P500.

Among 20 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 12 have Buy rating, 0 Sell and 8 Hold. Therefore 60% are positive. Biogen Idec Inc. had 41 analyst reports since July 23, 2015 according to SRatingsIntel. RBC Capital Markets maintained Biogen Inc (NASDAQ:BIIB) rating on Monday, July 27. RBC Capital Markets has “Outperform” rating and $450 target. The firm has “Market Perform” rating given on Friday, July 24 by BMO Capital Markets. Jefferies initiated it with “Buy” rating and $348 target in Wednesday, September 9 report. The firm has “Equal-Weight” rating given on Thursday, March 16 by Morgan Stanley. As per Thursday, June 1, the company rating was maintained by BMO Capital Markets. H.C. Wainwright initiated it with “Buy” rating and $380 target in Tuesday, August 11 report. The firm earned “Neutral” rating on Friday, March 11 by Robert W. Baird. The stock of Biogen Inc (NASDAQ:BIIB) has “Overweight” rating given on Friday, December 18 by Atlantic Securities. Bernstein upgraded Biogen Inc (NASDAQ:BIIB) on Monday, July 27 to “Outperform” rating. The rating was initiated by Standpoint Research with “Buy” on Thursday, January 7.

Investors sentiment decreased to 0.92 in Q4 2016. Its down 0.08, from 1 in 2016Q3. It turned negative, as 90 investors sold BIIB shares while 341 reduced holdings. 93 funds opened positions while 304 raised stakes. 183.23 million shares or 1.51% less from 186.04 million shares in 2016Q3 were reported. 333,925 were reported by Korea Investment Corp. Burt Wealth Advisors holds 75 shares or 0.02% of its portfolio. Gulf Comml Bank (Uk) Limited has invested 0.29% in Biogen Inc (NASDAQ:BIIB). Moreover, Hanson & Doremus Inv Management has 0% invested in Biogen Inc (NASDAQ:BIIB) for 525 shares. Cim Llc reported 29,367 shares or 4.18% of all its holdings. The Massachusetts-based Boston Private Wealth Llc has invested 0.02% in Biogen Inc (NASDAQ:BIIB). Proshare Advsr Limited Liability Company invested 0.55% in Biogen Inc (NASDAQ:BIIB). Arrow Financial reported 6,090 shares stake. Culbertson A N owns 820 shares. Sunbelt has invested 0% of its portfolio in Biogen Inc (NASDAQ:BIIB). Bb&T Ltd Liability Com holds 0.04% or 8,689 shares. Patten Group Inc Inc has 505 shares for 0.06% of their portfolio. Lakeview Ptnrs invested 0.24% of its portfolio in Biogen Inc (NASDAQ:BIIB). Bessemer Gp has invested 0% in Biogen Inc (NASDAQ:BIIB). 1,719 were reported by New Amsterdam Ptnrs Ltd Liability.

Teacher Retirement System Of Texas increased Torchmark Corp (NYSE:TMK) stake by 5,474 shares to 9,937 valued at $733,000 in 2016Q4. It also upped U S Silica Hldgs Inc (NYSE:SLCA) stake by 216,465 shares and now owns 223,303 shares. Service Corp Intl (NYSE:SCI) was raised too.

Since January 9, 2017, it had 2 insider buys, and 5 insider sales for $4.84 million activity. Sandrock Alfred also sold $542,952 worth of Biogen Inc (NASDAQ:BIIB) shares. Shares for $2.88 million were sold by Clancy Paul J on Monday, March 13. 5,450 shares valued at $1.61 million were sold by PANGIA ROBERT W on Monday, January 9. Posner Brian S sold 1,084 shares worth $277,840. $380,433 worth of Biogen Inc (NASDAQ:BIIB) shares were bought by Vounatsos Michel.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>